Prodrug-Based Cascade Self-Assembly Strategy for Precisely Controlled Combination Drug Therapy.

Area of Science:

• Biomaterials Science
• Drug Delivery Systems
• Nanotechnology

Background:

• Developing effective codelivery systems for combination therapy is challenging.
• Precisely controlling drug ratios and administration times in single carriers remains a hurdle.

Purpose of the Study:

• To create a prodrug-based cascade self-assembly strategy for supramolecular hydrogels.
• To enable staged drug loading and temporal/spatial drug release for combination therapy.

Main Methods:

• Prodrug micelle formation and cascade self-assembly.
• Morphological analysis of self-assembly mechanism.
• In vitro studies using tumor cell uptake and cytotoxicity assays.
• In vivo evaluation in a tumor-bearing animal model.

Main Results:

• Successfully constructed a supramolecular hydrogel capable of staged drug loading.
• Demonstrated temporal and spatial drug release via cascade disassembly.
• Validated the system's effectiveness in controlling drug ratios and administration timing.
• Confirmed therapeutic potential through cell and animal model studies.

Conclusions:

• The prodrug micelle-based cascade self-assembly system offers a novel approach for combination therapy.
• This strategy provides a new platform for developing multidrug-loaded carriers.
• The system shows promise for precise and effective therapeutic applications.